Sector Chart Resverlogix Corp. OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0694 USD | +2.06% |
|
+4.05% | -6.47% |
| 06-26 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-16 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 56.71B | |||||
| 51.3B | |||||
| 25.26B | - | ||||
| 23.65B | - | ||||
| 18.69B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
